← Leaderboards
Jonathan Peled
Sloan-Kettering Inst Can Research
$858,060
Attributed
$858,060
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $171.6K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$858,060 · 1
By mechanism
K08$858,060 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Robert Jenq$9,366,718
- Ying Taur$2,764,743
- Joao Xavier$14,255,503
- Robert A Soslow$575,920
- Doris Ponce$663,750
Others in their field
Other Emerging Leaders on “Commensal Bacteria”
- Gary Fanger · Rise Therapeutics, Llc$10,788,359
- Donna Muzny · Baylor College Of Medicine$4,437,671
- Terry Roemer · Prokaryotics, Inc.$4,415,869
- Andrea Reboldi · Univ Of Massachusetts Med Sch Worcester$4,280,954
- Anne Frey Luetkemeyer · University Of California, San Francisco$4,156,913
- Ansel Hsiao · University Of California Riverside$4,087,940
Research focus
Commensal BacteriaCommunitiesAffectClinical TrialsAllogenicCommensal MicrobesAntibiotic TherapyAntibody TherapyApplications GrantsAdvisory CommitteesAnimal ModelBacteriaAntibioticsBiological MarkersBiomarker DevelopmentBiomarker PanelBone Marrow TransplantationCancer PatientCancer RecurrenceCancer TherapyAwardAnimal ExperimentsClinically ActionableComplex
Grant awards (5)
Microbiota mechanisms and biomarkers in GVHD$171,612
K08 · FY2023 · HL · contact PI
Microbiota mechanisms and biomarkers in GVHD$171,612
K08 · FY2022 · HL · contact PI
Microbiota mechanisms and biomarkers in GVHD$171,612
K08 · FY2021 · HL · contact PI
Microbiota mechanisms and biomarkers in GVHD$171,612
K08 · FY2020 · HL · contact PI
Microbiota mechanisms and biomarkers in GVHD$171,612
K08 · FY2019 · HL · contact PI